Canopy Growth (CGC)

Canopy Growth (CGC) Stock Price & Analysis


CGC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.80 - $4.77
Previous Close$0.83
Average Volume (3M)6.99M
Market Cap
Enterprise Value$731.23M
Total Cash (Recent Filing)C$802.18M
Total Debt (Recent Filing)C$1.21B
Price to Earnings (P/E)-0.1
Aug 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.00
Shares Outstanding14,535,689
10 Day Avg. Volume11,492,688
30 Day Avg. Volume6,988,784
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)0.12
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside19.99% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Canopy Growth’s price range in the past 12 months?
Canopy Growth lowest stock price was $0.80 and its highest was $4.77 in the past 12 months.
    What is Canopy Growth’s market cap?
    Currently, no data Available
    When is Canopy Growth’s upcoming earnings report date?
    Canopy Growth’s upcoming earnings report date is Aug 09, 2023 which is in 65 days.
      How were Canopy Growth’s earnings last quarter?
      Canopy Growth released its earnings results on May 30, 2023. The company reported -$0.145 earnings per share for the quarter, beating the consensus estimate of -$0.153 by $0.007.
        Is Canopy Growth overvalued?
        According to Wall Street analysts Canopy Growth’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Canopy Growth pay dividends?
          Canopy Growth does not currently pay dividends.
          What is Canopy Growth’s EPS estimate?
          Canopy Growth’s EPS estimate is -$0.13.
            How many shares outstanding does Canopy Growth have?
            Canopy Growth has 494,894,040 shares outstanding.
              What happened to Canopy Growth’s price movement after its last earnings report?
              Canopy Growth reported an EPS of -$0.145 in its last earnings report, beating expectations of -$0.153. Following the earnings report the stock price went down -3.409%.
                Which hedge fund is a major shareholder of Canopy Growth?
                Among the largest hedge funds holding Canopy Growth’s share is Maverick Capital ltd. It holds Canopy Growth’s shares valued at 388K.


                  Canopy Growth Stock Smart Score

                  The Canopy Growth stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Canopy Growth

                  Canopy Growth Corp. engages in the production and sale of medical cannabis. The company offers products including oils and concentrates, soft gel capsules and hemp. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.


                  Top 5 ETFs holding CGC

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold CGC. The ETFs are listed according to market value of CGC within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Aurora Cannabis
                  Cronos Group
                  Curaleaf Holdings

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis